Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients [Phase 4]
Phase 4 clinical trial investigating dapagliflozin for efficacy and safety in improving heart failure among dialysis patients (recruiting).
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
A completed clinical trial from Imperial College London examining immunosuppressant medication adherence in kidney transplant patients; resu…
-
CLINICAL_TRIALS trial_result · 2024-04-11Clinical Trial Update: The Pristine Post-Market Study [NA]
The study was terminated; results have been posted for a post-market safety/efficacy evaluation related to dialysis-related conditions.
-
FDA approval · 2024-04-10FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA granted supplemental approval for Sevelamer Carbonate from Macleods Pharmaceuticals Limited under an ANDA.
-
CLINICAL_TRIALS research · 2024-04-09Clinical Trial Update: Supporting Self-Management of Healthy Behaviors in Chronic Kidney Disease [NA]
This ClinicalTrials.gov update notes the study is completed and results have been posted for a University of Pennsylvania trial evaluating s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-04-02FDA Approved: FUROSEMIDE — Original Application (Devatis Inc.)
FDA approved Devatis Inc.'s original application for a generic furosemide product, enabling its marketing in the United States.
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Phase 2b Study of KBP-5074 in Subjects With Uncontrolled Hypertension and Advanced Chronic Kidney Disease [Phase 2]
A Phase 2b trial of KBP-5074 in patients with uncontrolled hypertension and advanced chronic kidney disease has completed enrollment and pos…
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) [Phase 3]
The Phase 3 extended access program for bardoxolone methyl in chronic kidney disease was terminated, with results posted in March 2024. The …
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients [Phase 4]
A Phase 4 clinical trial evaluating neutrophil gelatinase-associated lipocalin (NGAL) in relation to vascular calcification in maintenance h…
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study [Phase 2, Phase 3]
A clinical trial update for dapagliflozin investigating protection against the transition from acute kidney injury to chronic kidney disease…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial investigating the effect of a low protein diet on top of dapagliflozin in patients with chronic kidney disease and type 2 diab…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: COVID-19 Testing in Underserved and Vulnerable Populations [NA]
Clinical trial with terminated status related to COVID-19 testing in underserved populations; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Effectiveness of the CDK-SMS Intervention for Adults [Phase 4]
Phase 4 clinical trial update evaluating the CDK-SMS intervention in adults with chronic renal insufficiency; study status is completed.
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy [Phase 3]
A Phase 3 trial evaluating subcutaneous semaglutide for improving kidney transplant candidacy in patients with chronic kidney disease and di…
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: Effectiveness of Trivalent Influenza Vaccine (TIV) in Type 2 Diabetes Mellitus (T2DM) Patients With and Without Complications of Chronic Kidney Disease (CKD) [Phase 4]
Phase 4 trial update evaluating the effectiveness of a trivalent influenza vaccine in patients with type 2 diabetes, with and without chroni…
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating adipose-derived stem cells for moderate to severe chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR) [Phase 4]
Phase 4 trial update evaluating finerenone effects on vascular stiffness and cardiorenal biomarkers in type 2 diabetes with chronic kidney d…
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease Patients [Phase 4]
Phase 4 trial update investigating low doses of a hypoxia-inducible factor–prolyl hydroxylase inhibitor with iron for treating anemia in dia…
-
CLINICAL_TRIALS trial_result · 2024-01-24Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus [Phase 2]
Phase 2 trial evaluating safety and efficacy of CR845 in chronic kidney disease patients with moderate-to-severe pruritus has completed with…
-
FDA approval · 2024-01-19FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Ferric Citrate by Mylan Pharmaceuticals Inc., marking regulatory authorization for an updated su…
-
FDA approval · 2024-01-19FDA Approved: RAYALDEE — Supplemental Application (OPKO Pharmaceuticals LLC)
FDA approved a supplemental application for RAYALDEE (calcifediol) from OPKO Pharmaceuticals LLC under NDA 208010, authorizing changes to th…
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease [Phase 4]
Phase 4 trial evaluating natriuresis-guided diuretic therapy in patients with acute heart failure with reduced ejection fraction and chronic…
-
CLINICAL_TRIALS trial_result · 2024-01-11Clinical Trial Update: Diuretic/Cool Dialysate Trial [NA]
Clinical trial update for a diuretic/cool dialysate study has been terminated; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients [Phase 2]
Phase 2 trial evaluating safety and efficacy of AP-306 in patients with hyperphosphatemia due to chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Low Dose Continuous Furosemide Effect on Cardiac Surgery Patients With Kidney Dysfunction [Phase 2]
Phase 2 clinical trial evaluating low dose continuous furosemide in cardiac surgery patients with kidney dysfunction has completed with resu…